title: Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe.
abstract: We report a large genomic deletion of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, viz., a deletion that is frequently observed in Central and Eastern Europe. The mutation, termed CFTRdele2,3(21 kb), deletes 21,080 bp spanning introns 1-3 of the CFTR gene. Transcript analyses have revealed that this deletion results in the loss of exons 2 and 3 in epithelial CFTR mRNA, thereby producing a premature termination signal within exon 4. In order to develop a simple polymerase chain reaction assay for this allele, we defined the end-points of the deletion at the DNA sequence level. We next screened for this mutation in a representative set of European and European-derived populations. Some 197 CF patients, including seven homozygotes, bearing this mutation have been identified during the course of our study. Clinical evaluation of CFTRdele2,3(21 kb) homozygotes and a comparison of compound heterozygotes for deltaF508/CFTRdele2,3(21 kb) with pairwise-matched deltaF508 homozygotes indicate that this deletion represents a severe mutation associated with pancreatic insufficiency and early age at diagnosis. Current data show that the mutation is particularly common in Czech (6.4% of all CF chromosomes), Russian (5.2%), Belorussian (3.3%), Austrian (2.6%), German (1.5%), Polish (1.5%), Slovenian (1.5%), Ukrainian (1.2%), and Slovak patients (1.1%). It has also been found in Lithuania, Latvia, Macedonia and Greece and has sporadically been observed in Canada, USA, France, Spain, Turkey, and UK, but not in CF patients from Bulgaria, Croatia, Romania or Serbia. Haplotype analysis has identified the same extragenic CF-haplotype XV-2c/KM. 19 "A" and the same infrequent intragenic microsatellite haplotype 16-33-13 (IVS8CA-IVS 17bTA-IVS 17bCA) in all examined CFTRdele2,3(21 kb) chromosomes, suggesting a common origin for this deletion. We conclude that the 21-kb deletion is a frequent and severe CF mutation in populations of Eastern- and Western-Slavic descent.
authors.affiliation: Institute of Human Genetics, Medical School Hannover, Germany. doerk.thilo@mh-hannover.de
authors.forename: T
authors.initials: T
authors.lastname: Dörk
authors.forename: M
authors.initials: M
authors.lastname: Macek
authors.forename: F
authors.initials: F
authors.lastname: Mekus
authors.forename: B
authors.initials: B
authors.lastname: Tümmler
authors.forename: J
authors.initials: J
authors.lastname: Tzountzouris
authors.forename: T
authors.initials: T
authors.lastname: Casals
authors.forename: A
authors.initials: A
authors.lastname: Krebsová
authors.forename: M
authors.initials: M
authors.lastname: Koudová
authors.forename: I
authors.initials: I
authors.lastname: Sakmaryová
authors.forename: M
authors.initials: M
authors.lastname: Macek
authors.forename: V
authors.initials: V
authors.lastname: Vávrová
authors.forename: D
authors.initials: D
authors.lastname: Zemková
authors.forename: E
authors.initials: E
authors.lastname: Ginter
authors.forename: N V
authors.initials: NV
authors.lastname: Petrova
authors.forename: T
authors.initials: T
authors.lastname: Ivaschenko
authors.forename: V
authors.initials: V
authors.lastname: Baranov
authors.forename: M
authors.initials: M
authors.lastname: Witt
authors.forename: A
authors.initials: A
authors.lastname: Pogorzelski
authors.forename: J
authors.initials: J
authors.lastname: Bal
authors.forename: C
authors.initials: C
authors.lastname: Zékanowsky
authors.forename: K
authors.initials: K
authors.lastname: Wagner
authors.forename: M
authors.initials: M
authors.lastname: Stuhrmann
authors.forename: I
authors.initials: I
authors.lastname: Bauer
authors.forename: H H
authors.initials: HH
authors.lastname: Seydewitz
authors.forename: T
authors.initials: T
authors.lastname: Neumann
authors.forename: S
authors.initials: S
authors.lastname: Jakubiczka
mesh_terms: D000483:Alleles; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000453:epidemiology / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D004252:DNA Mutational Analysis; D005060:Europe / Q000453:epidemiology; D005260:Female; D005787:Gene Frequency; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010641:Phenotype; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017384:Sequence Deletion
chemical_list: C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator